Canaccord Starts Eton Pharmaceuticals (ETON) at Buy
Tweet
Share
E-mailGet Alerts ETON Hot Sheet
Price: $55.31 -0.34%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
Canaccord analyst Gary Newman initiates coverage on Eton Pharmaceuticals (NASDAQ: ETON) with a Buy rating and a price target of $60.00.
For an analyst ratings summary and ratings history on Eton Pharmaceuticals click here. For more ratings news on Eton Pharmaceuticals click here.
Shares of Eton Pharmaceuticals closed at $38.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Raytheon wins $34 million contract for V-22 software support
- Iambic Therapeutics (IAM) files for proposed IPO
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
